Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape. Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing ... Read More
-
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly)
... Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly) The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. ... Read More
-
Global Flu Vaccine Market - 2022-2029
... during the forecast period (2022-2029). The flu vaccine is inactivated, indicating that it includes the killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Flue vaccination is safe ... Read More
-
Middle East & Africa Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in Middle East & Africa is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 ... Read More
-
Europe Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to US$ 3,424.02 million by 2028. It is estimated ... Read More
-
South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in South & Central America is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 ... Read More
-
Oncolytic Virus - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Oncolytic Virus: Understanding Oncolytic Virus: Overview Oncolytic viruses (OVs) are organisms able ... Read More
-
Oncolytic Virus - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Oncolytic Virus: Understanding Oncolytic Virus: Overview Oncolytic viruses (OVs) are organisms able to ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Haemophilus Influenzae Type B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Haemophilus influenzae Type B Infections (Infectious Disease) pipeline landscape. Haemophilus influenzae type B (Hib) is a bacterium that causes a life-threatening infection that can ... Read More
-
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... and Route of Administration (Injection and Nasal Spray) The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a ... Read More
-
Influenza Vaccine Market Intelligence Report - Global Forecast to 2027
... the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange ... Read More
-
Global Biotherapeutics Virus removal filters Market Size study, By Technology (Size Exclusion Technology, Depth Filtration Technology), By Application (Monoclonal Antibodies, Blood & Plasma, Enzymes, Proteins), By End User (Biopharmaceutical Companies, Clinical Research Organizations, Academic Institutes, Other End Users), and Regional Forecasts 2022-2028
... Other End Users), and Regional Forecasts 2022-2028 Global Biotherapeutics Virus removal filters Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX ... Read More
-
Adult Vaccines Market, by Vaccine (Influenza, Tetanus/Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster, Measles/mumps/Rubella, Pneumococcal, Hepatitis, and Others), by Vaccine Type (Monovalent and Multivalent), by Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Conjugate Vaccines), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Vaccines, and Conjugate Vaccines), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Vaccines refer to the biological preparation that ... Read More
-
Viral Vector Manufacturing Market Forecasts to 2028 – Global Analysis By Type (Pox Virus, Cytomegalovirus, Herpes Simplex Virus Vectors, Adenoviral Vectors), Application (Gene Therapy, Vaccinology) and By Geography
... Vector Manufacturing Market is accounted for $668.48 million in 2022 and is expected to reach $1,804.59 million by 2028 growing at a CAGR of 18.0% during the forecast period. Viral vectors are manufactured for delivering ... Read More
-
Influenza Diagnostics Global Market Opportunities And Strategies To 2031
... need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
-
Global Serological Testing Market Size study, by Technology (ELISA, NAT, CLIA/CMIA and Others), Product (Instruments and Consumables & Reagents), Application (Hepatitis, Coronavirus (COVID-19), Human Immunodeficiency Virus (HIV), Rotavirus Infections, And Others), End-User (Diagnostic Laboratories, Hospitals and Other End Users), and Regional Forecasts 2022-2028
... and Other End Users), and Regional Forecasts 2022-2028 Global Serological Testing Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% ... Read More
-
2022 Global Forecast for Avian Influenza Vaccines Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Global Infectious Disease Diagnostics Market Size study, By Product (Reagents, Kits, and Consumables, Instruments, Software & Services), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, Other technologies), By Disease Type (HIV, Hepatitis, HPV, Tuberculosis, Influenza, Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028
... Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028Global Infectious Disease Diagnostics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a ... Read More
-
Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus A and Influenza Virus B), by Age Group (Pediatrics and Adults), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccination for influenza aids in ... Read More
-
Human Immunodeficiency Virus (HIV) Drugs Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others); By Drug Class; By Region; Segment Forecast, 2022 - 2030
... Immunodeficiency Virus (HIV) drugs market size is expected treach USD 47.48 billion by 20230 according ta new study by Polaris Market Research. The report “Human Immunodeficiency Virus (HIV) Drugs Market Share, Size, Trends, Industry Analysis ... Read More
-
Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... H1N1 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline landscape. H1N1 Infection also called as swine flu is a new kind of ... Read More
-
Mono Vaccines (Epstein - Barr virus) Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... virus is known to cause various autoimmune disorders including multiple sclerosis, celiac disease, systemic lupus erythematosus, juvenile idiopathic arthritis, inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes. Various research studies have linked Epstein-Barr virus ... Read More
-
Influenza A Virus, H5N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... H5N1 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline landscape. H5N1 is a type of influenza virus that causes a highly infectious, ... Read More
-
Epstein-Barr Virus (HHV-4) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline landscape. Epstein-Barr virus (EBV) or human herpes virus 4 virus is a member of the Herpesviridae family. It is ... Read More
Research Assistance
